NCT03069183

Brief Summary

Total hip replacement (THR) is a common and major surgical procedure performed in elderly patients with significant comorbidities. Optimizing a patient's anesthetic and analgesic modalities could play a significant role in minimizing the risk of adverse events in the perioperative period and potentially shorten time to discharge and recovery. Establishing a safe and effective post-operative analgesic plan is of central importance to successful THR anesthesia care. The application of ultrasound visualization has improved the efficacy of the fascia iliaca compartment block (FICB). However, ultrasound-guided suprainguinal FICB has not yet been evaluated clinically in a large trial as a method of providing post-operative analgesia following THR. The investigators hypothesize that by performing the suprainguinal fascia iliaca block with ultrasound, it will be possible to achieve superior and more reliable analgesia in the first 24 hours than without a block.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
133

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Aug 2018

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 3, 2017

Completed
1.5 years until next milestone

Study Start

First participant enrolled

August 30, 2018

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 27, 2022

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

December 12, 2023

Status Verified

July 1, 2018

Enrollment Period

3.7 years

First QC Date

February 27, 2017

Last Update Submit

December 11, 2023

Conditions

Keywords

Fascia Iliaca BlockTotal Hip ArthroplastyTotal Hip ReplacementUltrasound

Outcome Measures

Primary Outcomes (1)

  • Opioid Consumption at 24 hours after arrival in post-operative care unit

    Opioid consumption at 24 hours after arrival in PACU amongst the various treatment groups will be our primary outcome. Opioid usage for the first 24 hours will be simply determined from the patient-controlled analgesia data in addition to oral narcotics administered.

    24 hours

Secondary Outcomes (5)

  • Pain Scores

    Every 4 hours after arrival in post-operative care unit for 24 hours

  • Respiratory Depression

    Every 4 hours after arrival in post-operative care unit for 24 hours

  • Nausea

    Every 4 hours after arrival in post-operative care unit for 24 hours

  • Vomiting

    Every 4 hours after arrival in post-operative care unit for 24 hours

  • Pruritus

    Every 4 hours after arrival in post-operative care unit for 24 hours

Study Arms (2)

0.5% Ropivacaine

ACTIVE COMPARATOR

Ultrasound-guided suprainguinal fascia iliaca compartment block with 40mls 0.5% ropivacaine.

Drug: 0.5% Ropivacaine

Normal Saline

PLACEBO COMPARATOR

Ultrasound-guided suprainguinal fascia iliaca compartment block with 40mls normal saline.

Drug: Normal saline

Interventions

Ultrasound-guided suprainguinal fascia iliaca compartment block with 40mls 0.5% ropivacaine.

Also known as: Naropin
0.5% Ropivacaine

Ultrasound-guided suprainguinal fascia iliaca compartment block with 40mls normal saline.

Normal Saline

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18-75, ASA I-III scheduled to undergo unilateral total hip arthroplasty.

You may not qualify if:

  • Patients not providing informed consent.
  • Refusal of treatment plan.
  • Pre-existing medical/neurological/hematologic conditions contraindicated for spinal anesthesia or peripheral nerve blocks.
  • Revision total hip arthroplasty.
  • Known allergy to any of the medications being used.
  • History of drug or alcohol abuse.
  • Patients with chronic pain on slow-release preparations of opioid in excess of 30mg of morphine equivalence per day.
  • Patients with Rheumatoid Arthritis.
  • Patients with psychiatric disorders.
  • Patients with prior surgery in the inguinal region or inguinal hernia
  • Patients unable or unwilling to use Patient Control Analgesia.
  • Diabetic patients with diabetic neuropathy or those with impaired renal function (Creatinine \>106).
  • Patients with BMI \>45.
  • Patients with body weight \<65kg.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Holland Orthopedic and Arthritic Centre

Toronto, Ontario, M2N 3Y7, Canada

Location

Related Publications (1)

  • Safa B, Trinh H, Lansdown A, McHardy PG, Gollish J, Kiss A, Kaustov L, Choi S. Ultrasound-guided suprainguinal fascia iliaca compartment block and early postoperative analgesia after total hip arthroplasty: a randomised controlled trial. Br J Anaesth. 2024 Jul;133(1):146-151. doi: 10.1016/j.bja.2024.04.019. Epub 2024 May 18.

MeSH Terms

Interventions

RopivacaineSaline Solution

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2017

First Posted

March 3, 2017

Study Start

August 30, 2018

Primary Completion

April 27, 2022

Study Completion

May 1, 2022

Last Updated

December 12, 2023

Record last verified: 2018-07

Locations